×
Should Buprenorphine Induction Dosing Be Lower for the Elderly Population With Opioid Use Disorder? A Case of Buprenorphine-Induced Hemodynamic Instability PDF
$ 40.00
Should Buprenorphine Induction Dosing Be Lower for the Elderly Population With Opioid Use Disorder? A Case of Buprenorphine-Induced Hemodynamic Instability PDF quantity
$ 40.00
×
Response to Missile Attacks on Civilian Targets in Patients With Panic Disorder. PDF
$ 40.00
Response to Missile Attacks on Civilian Targets in Patients With Panic Disorder. PDF quantity
$ 40.00
×
Ritonavir/Lopinavir and Its Potential Interactions With Psychiatric Medications: A COVID-19 Perspective PDF
$ 40.00
Ritonavir/Lopinavir and Its Potential Interactions With Psychiatric Medications: A COVID-19 Perspective PDF quantity
$ 40.00
×
The Texas Medication Algorithm Project Antipsychotic Algorithm for Schizophrenia: 2006 Update PDF
$ 40.00
The Texas Medication Algorithm Project Antipsychotic Algorithm for Schizophrenia: 2006 Update PDF quantity
$ 40.00
×
A Randomized Controlled Trial of Risperidone and Olanzapine for Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia PDF
$ 40.00
A Randomized Controlled Trial of Risperidone and Olanzapine for Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia PDF quantity
$ 40.00
×
Suvorexant for Primary Insomnia in a Patient at High Risk for Hypnotic Dependence PDF
$ 40.00
Suvorexant for Primary Insomnia in a Patient at High Risk for Hypnotic Dependence PDF quantity
$ 40.00
×
Metrifonate: Update on a New Antidementia Agent PDF
$ 40.00
Metrifonate: Update on a New Antidementia Agent PDF quantity
$ 40.00
×
Late-Onset Adrenoleukodystrophy Associated With Long-Standing Psychiatric Symptoms PDF
$ 40.00
Late-Onset Adrenoleukodystrophy Associated With Long-Standing Psychiatric Symptoms PDF quantity
$ 40.00
×
Combining Pharmacotherapy With Psychotherapeutic Management: Guidelines for Integration PDF
$ 40.00
Combining Pharmacotherapy With Psychotherapeutic Management: Guidelines for Integration PDF quantity
$ 40.00
×
Moving Forward PDF
$ 40.00
Moving Forward PDF quantity
$ 40.00
×
A Comparison Study of Body Dysmorphic Disorder and Obsessive-Compulsive Disorder PDF
$ 40.00
A Comparison Study of Body Dysmorphic Disorder and Obsessive-Compulsive Disorder PDF quantity
$ 40.00
×
Prognostic Subgroups for Citalopram Response in the STAR*D Trial PDF
$ 40.00
Prognostic Subgroups for Citalopram Response in the STAR*D Trial PDF quantity
$ 40.00
×
Extended Release Quetiapine Fumarate in Patients With Major Depressive Disorder: Suicidality Data From Acute and Maintenance Studies PDF
$ 40.00
Extended Release Quetiapine Fumarate in Patients With Major Depressive Disorder: Suicidality Data From Acute and Maintenance Studies PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart